title: Anti-IgE therapy as novel target for asthma-COPD overlap syndrome: More questions before celebration.
authors.affiliation: a Department of Respiratory and Critical Care Medicine , Second Affiliated Hospital of Zhejiang University, School of Medicine Hangzhou , Zhejiang , China , huahaoshen@zju.edu.cn.
authors.forename: Yang
authors.initials: Y
authors.lastname: Xia
authors.affiliation: a Department of Respiratory and Critical Care Medicine , Second Affiliated Hospital of Zhejiang University, School of Medicine Hangzhou , Zhejiang , China , huahaoshen@zju.edu.cn.
authors.forename: Wen
authors.initials: W
authors.lastname: Li
authors.affiliation: a Department of Respiratory and Critical Care Medicine , Second Affiliated Hospital of Zhejiang University, School of Medicine Hangzhou , Zhejiang , China , huahaoshen@zju.edu.cn.
authors.forename: Huahao
authors.initials: H
authors.lastname: Shen
mesh_terms: D000888:Antibodies, Anti-Idiotypic; D001249:Asthma; D006801:Humans; D000069444:Omalizumab; D029424:Pulmonary Disease, Chronic Obstructive; D000074079:Undifferentiated Connective Tissue Diseases
chemical_list: D000888:Antibodies, Anti-Idiotypic; C026408:anti-IgE antibodies; D000069444:Omalizumab